Arbutus Biopharma Corp

NASDAQ:ABUS 4:00:00 PM EDT

4.43

+0.03 (+0.68%)

7:59:09 PM EDT: $4.53 +0.10 (+2.26%)

Market Cap (Intraday)	849.21M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.27 Million
Adjusted EPS	-$0.03

See more estimates

10-Day MA	$4.35
50-Day MA	$3.59
200-Day MA	$3.40

See more pivots

Arbutus Biopharma Corp Stock, NASDAQ:ABUS

701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974

United States of America

Phone: +1.267.469.0914

Number of Employees: 73

http://www.arbutusbio.com

Description

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.